GRISACTIN 250 (Grisactin 250 microcrystalline 250 mg)
Generic Name: griseofulvin
Pill imprint GRISACTIN 250 has been identified as Grisactin 250 microcrystalline 250 mg.
Grisactin 250 is used in the treatment of dermatophytosis; onychomycosis, toenail; tinea capitis; tinea barbae; onychomycosis, fingernail (and more), and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Grisactin 250 microcrystalline 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- griseofulvin
- Imprint:
- GRISACTIN 250
- Strength:
- microcrystalline 250 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Wyeth-Ayerst Laboratories
More about Grisactin 250 (griseofulvin)
Consumer resources
- Other brands: Grifulvin V, Gris-PEG, Fulvicin U/F, Fulvicin P/G
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
